About
With the support of the Marie Skłodowska-Curie Actions programme, the GenDAI project will leverage metagenomic potential for advanced diagnostics, contributing to the development of personalised treatments. It aims to create an AI-supported medical diagnostics platform for microbiome profiling, generate new metagenomic datasets for patients with inflammatory bowel disease, and develop the GenDAI Diagnostics Workflow, focusing on implementing a fully automated data processing pipeline. Additionally, the project will establish a robust, cloud-based foundation for platform development, incorporating advanced data management and security infrastructure for long-term archiving (GenDAI Safe). It will also identify biomarkers, characterising microbiome profiles, and delivering user-friendly clinical reporting.